Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51.6M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
+503K
-
Total reported value, excl. options
-
$81.2M
-
Value change
-
+$2.39M
-
Put/Call ratio
-
0.03
-
Number of buys
-
30
-
Number of sells
-
-13
-
Price
-
$4.74
Significant Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q3 2024
71 filings reported holding ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share as of Q3 2024.
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 51.6M outstanding shares and own 32.81% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (3.87M shares), Propel Bio Management, LLC (2.45M shares), BlackRock, Inc. (2.07M shares), VANGUARD GROUP INC (1.94M shares), Sofinnova Investments, Inc. (1.51M shares), GEODE CAPITAL MANAGEMENT, LLC (749K shares), Nantahala Capital Management, LLC (654K shares), Alyeska Investment Group, L.P. (471K shares), Shay Capital LLC (450K shares), and STATE STREET CORP (432K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.